Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral iodine gargle to reduce salivary bacteria in patients undergoing cancer surgery
jRCT1071230048Completed
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of povidone-iodine in cancer. Primary endpoint: Change in salivary bacterial load after povidone-iodine gargling. Started Aug 2023; status: completed.
02
Drugs
povidone-iodine
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT1071230048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1071230048.